$65.90
0.030.05%
Pre-Market: 8:17 AM EDT
15 minutes delayed
Comments
Loading...
Incyte
INCYNASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Incyte (NASDAQ:INCY) Stock, Analyst Ratings, Price Targets, Forecasts
Incyte Corp has a consensus price target of $75.67 based on the ratings of 24 analysts. The high is $100 issued by Credit Suisse on February 16, 2023. The low is $48 issued by BMO Capital on July 2, 2024. The 3 most-recent analyst ratings were released by BMO Capital, Deutsche Bank, and TD Cowen on July 2, 2024, May 23, 2024, and May 1, 2024, respectively. With an average price target of $61 between BMO Capital, Deutsche Bank, and TD Cowen, there's an implied -7.44% downside for Incyte Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BMO Capital
Deutsche Bank
TD Cowen
Truist Securities
Oppenheimer
1calculated from analyst ratings
Analyst Ratings for Incyte
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/02/2024 | Buy Now | -27.16% | BMO Capital | Evan Seigerman | $52 → $48 | Downgrade | Market Perform → Underperform | Get Alert |
| 06/18/2024 | Buy Now | — | Cantor Fitzgerald | Eric Schmidt | — | Reiterates | → Neutral | Get Alert |
| 05/23/2024 | Buy Now | -16.54% | Deutsche Bank | James Shin | → $55 | Initiates | → Hold | Get Alert |
| 05/01/2024 | Buy Now | 21.4% | TD Cowen | Marc Frahm | $88 → $80 | Maintains | Buy | Get Alert |
| 05/01/2024 | Buy Now | 25.95% | Truist Securities | Srikripa Devarakonda | $84 → $83 | Reiterates | Buy → Buy | Get Alert |
| 05/01/2024 | Buy Now | -21.09% | BMO Capital | Evan Seigerman | $56 → $52 | Maintains | Market Perform | Get Alert |
| 04/24/2024 | Buy Now | 27.47% | Oppenheimer | Jay Olson | $92 → $84 | Maintains | Outperform | Get Alert |
| 04/23/2024 | Buy Now | — | Cantor Fitzgerald | Eric Schmidt | — | Initiates | → Neutral | Get Alert |
| 03/25/2024 | Buy Now | -1.37% | RBC Capital | Brian Abrahams | → $65 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 03/13/2024 | Buy Now | 1.67% | B of A Securities | Tazeen Ahmad | $69 → $67 | Maintains | Neutral | Get Alert |
| 03/12/2024 | Buy Now | 3.19% | Stifel | Stephen Willey | → $68 | Reiterates | Hold → Hold | Get Alert |
| 03/12/2024 | Buy Now | -1.37% | RBC Capital | Brian Abrahams | → $65 | Reiterates | Sector Perform → Sector Perform | Get Alert |
| 02/23/2024 | Buy Now | 22.91% | Jefferies | Kelly Shi | → $81 | Initiates | → Buy | Get Alert |
| 02/14/2024 | Buy Now | — | JMP Securities | Reni Benjamin | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 02/14/2024 | Buy Now | -2.88% | BMO Capital | Evan Seigerman | $58 → $64 | Maintains | Market Perform | Get Alert |
| 02/14/2024 | Buy Now | 22.91% | Citigroup | David Lebowitz | $82 → $81 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | -1.37% | RBC Capital | Brian Abrahams | $63 → $65 | Maintains | Sector Perform | Get Alert |
| 02/14/2024 | Buy Now | 3.19% | Stifel | Stephen Willey | $67 → $68 | Maintains | Hold | Get Alert |
| 02/14/2024 | Buy Now | 27.47% | Truist Securities | Srikripa Devarakonda | $91 → $84 | Maintains | Buy | Get Alert |
| 12/14/2023 | Buy Now | 16.84% | Mizuho | Mara Goldstein | $82 → $77 | Maintains | Neutral | Get Alert |
| 12/13/2023 | Buy Now | 41.12% | JMP Securities | Reni Benjamin | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 12/13/2023 | Buy Now | 18.36% | Leerink Partners | Andrew Berens | → $78 | Upgrade | Market Perform → Outperform | Get Alert |
| 12/04/2023 | Buy Now | — | Guggenheim | Michael Schmidt | — | Upgrade | Neutral → Buy | Get Alert |
| 11/29/2023 | Buy Now | 38.09% | Truist Securities | Srikripa Devarakonda | → $91 | Reiterates | Buy → Buy | Get Alert |
| 11/22/2023 | Buy Now | -1.37% | Goldman Sachs | Salveen Richter | $98 → $65 | Maintains | Neutral | Get Alert |
| 11/21/2023 | Buy Now | -1.37% | Goldman Sachs | Salveen Richter | → $65 | Downgrade | Buy → Neutral | Get Alert |
| 11/02/2023 | Buy Now | 48.71% | Goldman Sachs | Salveen Richter | $114 → $98 | Maintains | Buy | Get Alert |
| 11/01/2023 | Buy Now | -4.4% | RBC Capital | Brian Abrahams | $74 → $63 | Maintains | Sector Perform | Get Alert |
| 11/01/2023 | Buy Now | -2.88% | Morgan Stanley | Vikram Purohit | $74 → $64 | Maintains | Equal-Weight | Get Alert |
| 09/21/2023 | Buy Now | 38.09% | Truist Securities | Srikripa Devarakonda | → $91 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 10.77% | RBC Capital | Brian Abrahams | $70 → $73 | Maintains | Sector Perform | Get Alert |
| 08/02/2023 | Buy Now | 15.33% | Stifel | Stephen Willey | $73 → $76 | Maintains | Hold | Get Alert |
| 08/02/2023 | Buy Now | 12.29% | Morgan Stanley | Vikram Purohit | $74 → $74 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 08/02/2023 | Buy Now | 41.12% | JMP Securities | Reni Benjamin | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/02/2023 | Buy Now | 3.19% | BMO Capital | Evan Seigerman | $70 → $68 | Maintains | Market Perform | Get Alert |
| 08/02/2023 | Buy Now | 38.09% | Truist Securities | Srikripa Devarakonda | $100 → $91 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 39.61% | Oppenheimer | Jay Olson | → $92 | Reiterates | Outperform → Outperform | Get Alert |
| 07/25/2023 | Buy Now | 41.12% | JMP Securities | Reni Benjamin | → $93 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 07/25/2023 | Buy Now | 24.43% | Citigroup | David Lebowitz | → $82 | Initiates | → Buy | Get Alert |
| 07/20/2023 | Buy Now | 12.29% | Morgan Stanley | Vikram Purohit | $74 → $74 | Reiterates | Underweight → Underweight | Get Alert |
| 05/04/2023 | Buy Now | 27.47% | B of A Securities | Tazeen Ahmad | $93 → $84 | Downgrade | Buy → Neutral | Get Alert |
| 05/04/2023 | Buy Now | 41.12% | JMP Securities | Reni Benjamin | $113 → $93 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 6.22% | BMO Capital | Evan Seigerman | $75 → $70 | Maintains | Market Perform | Get Alert |
| 05/03/2023 | Buy Now | 41.12% | TD Cowen | Marc Frahm | $100 → $93 | Maintains | Outperform | Get Alert |
| 05/03/2023 | Buy Now | 6.22% | RBC Capital | Brian Abrahams | $79 → $70 | Maintains | Sector Perform | Get Alert |
| 05/03/2023 | Buy Now | 12.29% | Morgan Stanley | Vikram Purohit | $77 → $74 | Maintains | Underweight | Get Alert |
| 05/03/2023 | Buy Now | 10.77% | Stifel | Stephen Willey | $80 → $73 | Maintains | Hold | Get Alert |
| 05/03/2023 | Buy Now | 24.43% | Mizuho | Mara Goldstein | $95 → $82 | Maintains | Neutral | Get Alert |
| 04/19/2023 | Buy Now | 71.47% | JMP Securities | Reni Benjamin | → $113 | Reiterates | → Market Outperform | Get Alert |
| 04/12/2023 | Buy Now | 16.84% | Morgan Stanley | Vikram Purohit | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 04/10/2023 | Buy Now | 19.88% | RBC Capital | Brian Abrahams | $81 → $79 | Downgrade | Outperform → Sector Perform | Get Alert |
| 03/28/2023 | Buy Now | 71.47% | JMP Securities | Reni Benjamin | → $113 | Reiterates | → Market Outperform | Get Alert |
| 03/20/2023 | Buy Now | -8.95% | SVB Leerink | Andrew Berens | $63 → $60 | Maintains | Underperform | Get Alert |
| 03/07/2023 | Buy Now | 71.47% | JMP Securities | Reni Benjamin | → $113 | Reiterates | → Market Outperform | Get Alert |
| 02/16/2023 | Buy Now | 51.75% | Credit Suisse | Srikripa Devarakonda | $95 → $100 | Maintains | Buy | Get Alert |
| 02/13/2023 | Buy Now | 71.47% | JMP Securities | Reni Benjamin | → $113 | Reiterates | → Market Outperform | Get Alert |
| 02/08/2023 | Buy Now | 51.75% | Cowen & Co. | Marc Frahm | $95 → $100 | Maintains | Outperform | Get Alert |
| 02/08/2023 | Buy Now | 51.75% | Piper Sandler | Allison Bratzel | → $100 | Maintains | Overweight | Get Alert |
| 02/08/2023 | Buy Now | 21.4% | JP Morgan | Jessica Fye | $82 → $80 | Maintains | Neutral | Get Alert |
| 02/08/2023 | Buy Now | 44.16% | Mizuho | Mara Goldstein | → $95 | Maintains | Neutral | Get Alert |
| 02/08/2023 | Buy Now | -4.4% | SVB Leerink | Andrew Berens | → $63 | Reiterates | → Underperform | Get Alert |
| 02/06/2023 | Buy Now | 71.47% | JMP Securities | Reni Benjamin | → $113 | Reiterates | → Market Outperform | Get Alert |
| 01/31/2023 | Buy Now | 51.75% | Piper Sandler | Allison Bratzel | → $100 | Initiates | → Overweight | Get Alert |
| 01/03/2023 | Buy Now | 13.81% | Wells Fargo | Derek Archila | $72 → $75 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | Buy Now | 24.43% | RBC Capital | Brian Abrahams | $77 → $82 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | 16.84% | Morgan Stanley | Vikram Purohit | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 10/24/2022 | Buy Now | 21.4% | JP Morgan | Jessica Fye | $86 → $80 | Maintains | Neutral | Get Alert |
| 10/18/2022 | Buy Now | 13.81% | Wells Fargo | Derek Archila | $76 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | 18.36% | Evercore ISI Group | Maneka Mirchandaney | $90 → $78 | Downgrade | Outperform → In-Line | Get Alert |
| 08/03/2022 | Buy Now | 15.33% | Morgan Stanley | Vikram Purohit | $77 → $76 | Maintains | Equal-Weight | Get Alert |
| 08/03/2022 | Buy Now | — | Guggenheim | Michael Schmidt | — | Downgrade | Buy → Neutral | Get Alert |
| 07/28/2022 | Buy Now | 15.33% | Wells Fargo | Derek Archila | → $76 | Initiates | → Equal-Weight | Get Alert |
| 07/20/2022 | Buy Now | -4.4% | SVB Leerink | Andrew Berens | $58 → $63 | Maintains | Underperform | Get Alert |
| 05/05/2022 | Buy Now | 16.84% | Morgan Stanley | Vikram Purohit | $76 → $77 | Maintains | Equal-Weight | Get Alert |
| 05/04/2022 | Buy Now | 33.54% | RBC Capital | Brian Abrahams | $89 → $88 | Maintains | Outperform | Get Alert |
| 05/04/2022 | Buy Now | -11.99% | SVB Leerink | Andrew Berens | $56 → $58 | Maintains | Underperform | Get Alert |
| 04/20/2022 | Buy Now | 15.33% | Morgan Stanley | Vikram Purohit | $73 → $76 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | Buy Now | -15.02% | SVB Leerink | Andrew Berens | $60 → $56 | Downgrade | Market Perform → Underperform | Get Alert |
| 02/02/2022 | Buy Now | 15.33% | Morgan Stanley | Vikram Purohit | $77 → $76 | Maintains | Equal-Weight | Get Alert |
| 01/18/2022 | Buy Now | 36.57% | RBC Capital | Brian Abrahams | $78 → $90 | Upgrade | Sector Perform → Outperform | Get Alert |
| 11/19/2021 | Buy Now | 13.81% | BMO Capital | Evan Seigerman | — | Initiates | → Market Perform | Get Alert |
| 11/04/2021 | Buy Now | 63.88% | JMP Securities | Reni Benjamin | — | Maintains | Market Outperform | Get Alert |
| 11/03/2021 | Buy Now | 65.4% | Oppenheimer | Jay Olson | — | Maintains | Outperform | Get Alert |
| 09/23/2021 | Buy Now | 21.4% | Morgan Stanley | Vikram Purohit | — | Maintains | Equal-Weight | Get Alert |
| 09/23/2021 | Buy Now | 30.5% | RBC Capital | Brian Abrahams | — | Maintains | Sector Perform | Get Alert |
| 09/23/2021 | Buy Now | 0.15% | SVB Leerink | Andrew Berens | — | Upgrade | Underperform → Market Perform | Get Alert |
| 08/04/2021 | Buy Now | 1.67% | SVB Leerink | Andrew Berens | — | Maintains | Underperform | Get Alert |
FAQ
What is the target price for Incyte (INCY) stock?
The latest price target for Incyte (NASDAQ:INCY) was reported by BMO Capital on July 2, 2024. The analyst firm set a price target for $48.00 expecting INCY to fall to within 12 months (a possible -27.16% downside). 39 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Incyte (INCY)?
The latest analyst rating for Incyte (NASDAQ:INCY) was provided by BMO Capital, and Incyte downgraded their underperform rating.
When was the last upgrade for Incyte (INCY)?
The last upgrade for Incyte Corp happened on December 13, 2023 when Leerink Partners raised their price target to $78. Leerink Partners previously had a market perform for Incyte Corp.
When was the last downgrade for Incyte (INCY)?
The last downgrade for Incyte Corp happened on July 2, 2024 when BMO Capital changed their price target from $52 to $48 for Incyte Corp.
When is the next analyst rating going to be posted or updated for Incyte (INCY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Incyte, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Incyte was filed on July 2, 2024 so you should expect the next rating to be made available sometime around July 2, 2025.
Is the Analyst Rating Incyte (INCY) correct?
While ratings are subjective and will change, the latest Incyte (INCY) rating was a downgraded with a price target of $52.00 to $48.00. The current price Incyte (INCY) is trading at is $65.90, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.